Back to Calendar of events
 

Workshop on Biosimilars (14-15 February 2008)

This Workshop on Biosimilars was held from 14th to 15th February 2008 at the Kuala Lumpur Convention Centre and was organized by the Legal & Regulatory Department of BiotechCorp. The workshop was opened by Razif Abdul Aziz, Vice President of Legal & Regulatory, BiotechCorp.

The workshop attracted around 100 participants from the pharmaceutical (local and MNC) and biotech industry, regulators from the National Pharmaceutical Control Bureau, from universities as well as one keen biotech manufacturer from India. The two-day workshop was the first conducted on biosimilar by BiotechCorp.


The workshop was aimed at creating awareness and understanding on the requirements for registering a biosimilar product and similar biological medicinal products globally as well as on all the regulatory implications of process change and how to develop regulatory compliance strategies. Featuring case studies and interactive sessions, this workshop provided a guide to finding the best ways to satisfy the needs of the regulators and understand how various process changes may impact the success of a biosimilar product.




Mr Cecil Nick, Principal Consultant, PAREXEL Consulting, UK was the sole presenter for the two full day workshop. Mr Nick has more than 25 years of experience in regulatory affairs and worked for various Bio/pharmaceutical and healthcare companies including Novo Nordisk, Lundbeck, LIG, May & Baker and Farmitalia. Mr Nick has extensive experience in the development and EU registration of biotechnology and blood products, devices, new chemical entities, orphan drugs, EU marketing regulations and scientific advice. He diligently responded to all queries pertaining to the regulations.

Key topics covered:

  • Biologicals introductory
  • Spectrum of complexity
  • Immunogenicity
  • Comparability assessment
  • Demonstration of similarity
  • EU Regulations relating to biosimilars
  • EU Guidelines and quality data requirements
  • Clinical & non-clinical developments
  • Case study
  • Commercial considerations

 

 

 

 

Home | Biotech In Malaysia | About Us | One Stop Centre | The BioNexus Network | Grants & Programmes | Events |
Media Room
| Contact Us | Useful Links | Disclaimer